AD is a neurodegenerative disease, and its frequency is often reported to be higher for
women than men: almost two-thirds of patients with AD are women. One prevailing view is …

Estrogen is a fundamental regulator of the metabolic system of the female brain and body.
Within the brain, estrogen regulates glucose transport, aerobic glycolysis, and mitochondrial …

Clinical studies indicate that Alzheimer's disease (AD) disproportionately affects women in
both disease prevalence and rate of symptom progression, but the mechanisms underlying …

Objective: Our objective was to provide a scholarly review of the published literature on
menopausal hormonal therapy (MHT), make scientifically valid assessments of the available …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that accounts for
more than half of all dementia cases in the elderly. Interestingly, the clinical manifestations of …

Background: Dementia is a large and growing problem but is often not diagnosed in its
earlier stages. Screening and earlier treatment could reduce the burden of suffering of this …

Sex differences in neurological disease extend from incidence, severity, progression and
symptoms and may ultimately influence treatment. Cognitive disturbances are frequent in …

Multiple sclerosis patients who become pregnant experience a significant decrease in
relapses that may be mediated by a shift in immune responses from T helper 1 to T helper 2 …

The primary aim of the current study was to examine whether neurocognitive functioning
among breast cancer survivors (BCS) exposed to systemic adjuvant chemotherapy differs …

Alzheimer's disease affects nearly 5 million Americans currently and, as a result of the baby
boomer cohort, is predicted to affect 14 million Americans and 22 million persons totally …